New pain drug TT5 enters first human trials
Symptom relief
Recruiting now
This early-stage study aims to test the safety and side effects of an experimental pain medication called TT5. Researchers will give increasing doses to healthy volunteers and surgical patients to see how the body handles the drug. The main goal is to determine if TT5 is safe eno…
Phase: PHASE1 • Sponsor: Tafalgie Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 03:41 UTC